Evidence map›Paper›PMID 40951880›Full record

Article3 Biotech2025

In vitro anticancer activity of prodeoxyviolacein produced by

Nabil Miled, Mohamed Koubaa, Abdullah G Bagarish, Mohammed Alkhaled, Mehal A Alqriqri, Hawazen H Bin-Melaih, Espérance Debs, Nicolas Louka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nabil MiledDepartment of Biological Sciences, College of Science, University of Jeddah, 23445 Jeddah, Saudi Arabia.ORCID 0000-0001-7445-6324
Mohamed Koubaa *Université de technologie de Compiègne, Ecole Supérieure de Chimie Organique et Minérale, TIMR (Integrated Transformations of Renewable Matter), Centre de recherche Royallieu, CS 60319, 60203 Compiègne Cedex, France.
Abdullah G Bagarish *Department of Biological Sciences, College of Science, University of Jeddah, 23445 Jeddah, Saudi Arabia.
Mohammed AlkhaledDepartment of Biological Sciences, College of Science, University of Jeddah, 23445 Jeddah, Saudi Arabia.
Mehal A AlqriqriRegenerative Medicine Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Hawazen H Bin-MelaihDepartment of Biological Sciences, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Espérance DebsDepartment of Biology, Faculty of Arts and Sciences, University of Balamand, P.O. Box 100, Tripoli, 1300 Lebanon.
Nicolas LoukaCentre d'Analyses et de Recherche, Unité de Recherche Technologies et Valorisation Agro-Alimentaire, Faculté des Sciences, Université Saint-Joseph de Beyrouth, Mar Roukos - Dekwaneh, Riad El Solh, P. O. Box 1514, Beirut, 1107 2050 Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial dyes, known for their biological activities, have been considered as an eco-friendly alternative to the toxic chemicals widely used in various industrial fields such as food, pharmaceuticals, textiles, and cosmetics. The green dye prodeoxyviolacein was produced by fermentation using an engineered strain of the yeast

Indexed as

Anticancer activityApoptosisCell cycle arrestProdeoxyviolaceinYarrowia lipolytica

Identifiers

PMID40951880
PMCPMC12431995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.